Table 1.
Patient characteristics
| Characteristic | Patients |
|---|---|
| Total number of patients treated | 40 |
| Sex, n (%) | |
| Male | 17 (42.5) |
| Female | 23 (57.5) |
| Age, years | |
| Median | 51.5 |
| Range | 28–79 |
| ECOG performance status, n (%) | |
| 0 | 9 (22.5) |
| 1 | 29 (72.5) |
| 2 | 1 (2.5) |
| 3 | 1 (2.5) |
| Tumor type, n (%) | |
| Gynecologic tumors | 7 (17.5) |
| Breast | 5 (12.5) |
| Pancreatic | 6 (15) |
| Skin, including melanoma | 5 (12.5) |
| Gastrointestinal | 4 (10) |
| Bladder | 4 (10) |
| NSCLC | 1 (2.5) |
| Other | 8 (20) |
| Previous therapies, n (%) | |
| Surgery | 36 (90) |
| Chemotherapy | 39 (98) |
| Of which taxane therapy | 8 (20) |
| Radiotherapy | 19 (48) |
| Immunotherapy | 3 (8) |
| Hormone therapy | 5 (13) |
| Other | 4 (10) |
| No of prior chemotherapies, n (%) | |
| 0 | 1 (3) |
| 1 | 7 (18) |
| 2 | 10 (25) |
| ≥3 | 22 (55) |
NSCLC non-small cell lung cancer